Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2007
05/10/2007WO2006037095A3 Spatially-defined modification of fresh tissue using covalent chemistry
05/10/2007WO2006036826A3 Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
05/10/2007WO2006031312A3 Compositions and treatments using ex vivo activated cells for myelosuppressed patients
05/10/2007WO2006007124A3 Nucleic acid sequences encoding cel ii endonuclease
05/10/2007WO2005113776A3 Expression cassette
05/10/2007WO2005084276A3 Cell therapy formulation method and composition
05/10/2007US20070107102 Maize Hybrid Variety 34M78
05/10/2007US20070107101 Hybrid Maize Plant and Seed X5P505
05/10/2007US20070107100 Maize Hybrid Variety 33F12
05/10/2007US20070107099 Maize Hybrid Variety X5T123
05/10/2007US20070107098 Maize Hybrid Variety X5H332
05/10/2007US20070107097 Maize Hybrid Variety X5H310
05/10/2007US20070107096 Maize Hybrid Variety X5K673
05/10/2007US20070107095 Maize Hybrid Variety X5K655
05/10/2007US20070107094 Maize Hybrid Variety X5K664
05/10/2007US20070107093 Maize Hybrid Variety X5K677
05/10/2007US20070107092 Maize Hybrid Variety X4T962
05/10/2007US20070107091 Maize Hybrid Variety X5M895
05/10/2007US20070107090 Maize Hybrid Variety 33H82
05/10/2007US20070107089 corn plants and seeds, comprising a transgene that confers traits selected from male sterility, site-specific recombination, abiotic stress tolerance, altered phosphorus, antioxidants, fatty acids, essential amino acids and carbohydrates, disease, herbicide and insect resistance
05/10/2007US20070107088 Maize Hybrid Variety 32N89
05/10/2007US20070107086 NT-1 plant cell line stably transformed to express a transgene encoding a proteinaceous vaccine antigen; does not support growth of Mycoplasmataceae; contains no materials of animal origin; Potassium Phosphate, Dibasic, Sucrose, Batch Salts; consistent transgene expression recovered from cryopreservation
05/10/2007US20070107085 Process for proteolytic cleavage and purification of recombinant proteins produced in plants
05/10/2007US20070107084 Dof (DNA binding with one finger) sequences and methods of use
05/10/2007US20070107083 Method for regulating plant growth
05/10/2007US20070107081 Generating cyclyzed triterpenes in soybean for treatment and prevention of high blood cholesterol and heart disease
05/10/2007US20070107080 Production of 3-hydropropionic acid using beta-alanine/pyruvate aminotransferase
05/10/2007US20070107079 Plant cell death system
05/10/2007US20070107078 Methods to confer herbicide resistance
05/10/2007US20070107076 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
05/10/2007US20070107075 Disruptions in GABA Receptor RHO2 Subunit, Methods and Uses Thereof
05/10/2007US20070107073 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
05/10/2007US20070107071 Use of regulatory sequences for specific, transient expression in neuronal determined cells
05/10/2007US20070106201 Method and System for Myocardial Infarction Repair
05/10/2007US20070106070 T cell costimulatory molecule genes; used to identify components of the signal transduction pathway induced in a cell
05/10/2007US20070106069 Non-Human Primate Fc Receptors and Methods of Use
05/10/2007US20070106068 Nucleotide sequences coding Zcytor16 specific immunoglobulin for use in prevention and treatment of nervous system, inflammatory and autoimmune disorders
05/10/2007US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines
05/10/2007US20070105815 Biocompatible poly-beta-1-4-N-acetylglucosamine
05/10/2007US20070105806 Administering to a patient in needs of treatment, prevention or management of neuropathic pain, a therapeutically or prophylactically effective amount of a double-stranded RNA (dsRNA), consists of a sense strand and an antisense strand that are complementary to each other
05/10/2007US20070105795 Gene expression suppression agents
05/10/2007US20070105777 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/10/2007US20070105224 Genetic modification of liver cells to enhance metabolic and physiological efficacy
05/10/2007US20070105222 In vitro growth of tissues suitable to the formation of bone and bone forming tissue formed thereby
05/10/2007US20070105221 Method of isolating and culturing mesenchymal stem cell derived from cryopreserved umbilical cord blood
05/10/2007US20070105220 Reconstituting lyophillized erythrocytes with a solution of trehalose or another oligosaccharide solute having a concentration large enough to produce hyperosmotic pressure on the cell to transfer the solute from the solution into the cell
05/10/2007US20070105219 Retrovirus from the HIV group and its use
05/10/2007US20070105218 Lupus antibodies for passive immunotherapy of hiv/aids
05/10/2007US20070105217 comprising a chemotactic hematopoietic stem cell product and methods of use thereof in repairing injury caused by vascular insufficiency, including infarcted myocardium; contains a subpopulation of potent CD34+/chemokine receptor type 4 (CXCR-4+) cells
05/10/2007US20070105216 Method for the controlled release of calcium from intracellular calcium stores of oocytes
05/10/2007US20070105215 Method of culturing stem cells using abc transporters
05/10/2007US20070105199 Methods for generating monovalent IgG
05/10/2007US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector
05/10/2007US20070105188 determining sperm quality, and different storage media's effect thereon; male fertility
05/10/2007US20070105161 Identifying gamma -secretase inhibitors that exhibit reduced induction of goblet cell metaplasia; detecting mucin-2 induction or mucin-5AC induction in Notch expressing HT29 cells contacted with a compound that inhibits gamma -secretase
05/10/2007US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility
05/10/2007US20070105143 Novel bHLH type transcription factor genes
05/10/2007US20070105133 Compositions and methods for treating and diagnosing cancer
05/10/2007US20070105127 DNA libraries comprising vector constructs coding glycosylation enzymes and organelle targeting signal sequences for use in modifying exogenously expressed polypeptides
05/10/2007US20070105112 Laccases, nucleic acids encoding them and methods for making and using them
05/10/2007US20070105098 Isolation and use of ryanodine receptors
05/10/2007US20070105096 Endocrine cell lines and methods of using same
05/10/2007US20070105092 Proteolytic and covalent antibodies
05/10/2007US20070104732 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
05/10/2007US20070104726 Multimeric complexes of antigens and adjuvants
05/10/2007US20070104724 Attaching substances to microorganisms
05/10/2007US20070104720 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
05/10/2007US20070104713 Nogo receptor homologs
05/10/2007US20070104712 Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors
05/10/2007US20070104699 Compositions for and methods of granzyme B inhibition
05/10/2007US20070104697 Treatment of neural injury and neurodegenerative diseases by administering adipose tissue-derived stromal cells; stroke, traumatic brain injury, spinal cord injury and Parkinson's disease; inducing neurorestorative pathways in the brain; activating the neural cell differentiation in an injured brain
05/10/2007US20070104696 Use of cell lines to produce active therapeutic proteins
05/10/2007US20070104695 Breast augmentation and reconstruction system
05/10/2007US20070104694 Breast stimulation and augmentation system
05/10/2007US20070104693 Breast augmentation system
05/10/2007US20070104692 Breast tissue regeneration
05/10/2007US20070104691 Follicular fluid for prolonged growth and survival of cells for cell therapies
05/10/2007US20070104690 Retroviral vectors
05/10/2007US20070104679 Induction of differentiation of stem cells, and control of differentiation potency of stem cells
05/10/2007US20070104647 Ovr115 antibody compositions and methods of use
05/10/2007CA2637281A1 Methods of islet separation during isolation
05/10/2007CA2628408A1 Conditionally-immortalised pancreatic cells
05/10/2007CA2628255A1 Compositions and methods for treating and diagnosing cancer
05/10/2007CA2628221A1 Compositions and methods for diagnosing and treating cancer
05/10/2007CA2627667A1 Processing of angiogenic scaffolds for large organ regeneration
05/10/2007CA2627533A1 Stability of secondary metabolite mass production through syncronized plant cell cultures
05/10/2007CA2617723A1 Novel cxc-chemokine antagonists
05/10/2007CA2612479A1 Production of bone morphogenic proteins (bmps) in transgenic mammals
05/10/2007CA2610265A1 Methods for producing micrornas
05/09/2007EP1783645A1 Methods for the identification of microRNA and their applications in research and human health
05/09/2007EP1783489A1 Method of separating small hepatocytes by using specific antibody
05/09/2007EP1783229A2 GTP binding stress-related proteins and methods of use in plants
05/09/2007EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor
05/09/2007EP1783226A1 AAV structural protein, production and use thereof
05/09/2007EP1783225A1 AAV structural protein, production and use thereof
05/09/2007EP1783223A1 Fungal transcriptional activator PRTT from Aspergillus niger, useful in methods for producing polypeptides
05/09/2007EP1783222A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity.
05/09/2007EP1783221A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
05/09/2007EP1783219A1 Method of searching for novel drug discovery targets
05/09/2007EP1783218A1 Hcv rna having novel sequence
1 ... 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 ... 1827